SEC filings and other documents

Q2 2026 saw solid margins, cash flow despite revenue drop; AI and digital innovation to drive future growth.

Q1 2026 delivered strong margins and improved retention despite a 6% revenue decline year-over-year.

Strategic focus on data, integration, and innovation is driving retention and new growth channels.

Revenue and profitability beat guidance, retention improved, and claims data disruption was resolved.

Q3 revenue and profit exceeded guidance, with improved renewals and digital expansion, but growth headwinds persist.

Turnaround strategy drives stability, renewal gains, and innovation amid sector headwinds.

Q2 beat guidance with improved retention, but macro and Life Sciences headwinds persist.

Q1 revenue and EBITDA beat guidance, but retention and macro headwinds persist.

Turnaround strategy leverages data partnerships, operational changes, and cost actions for 2025-26 growth.

Q4 results topped guidance, but churn and revenue pressure persist, especially in life sciences.